Pfizer starts early-stage trial of combined Covid/flu vaccine

Pfizer has announced it has started early-stage trials of a combined Covid and flu jab (Kirsty O’Connor/PA)

Pharmaceutical giant Pfizer has launched an early-stage study of a combined Covid/flu vaccine.

The firm, which is partnering with BioNTech, said the first patient was given a dose this week of the vaccine, which combines a flu shot and Pfizer’s bivalent Covid vaccine designed to tackle the Omicron variant.